AI-enhanced breast cancer screening
Open for applications
AI-enhanced breast cancer screening
21-100 employees
Open for applications
21-100 employees
To ensure that every deadly breast cancer is detected early.
Jump to section
To ensure that every deadly breast cancer is detected early.
Some candidates hear
back within 2 weeks
29% employee growth in 12 months
Early detection is a critical factor in the battle against breast cancer, a disease that afflicts 2.1 women worldwide each year and ranks as the most prevalent cancer among women. Vara, an innovative player in the healthcare sector, is committed to enhancing survival rates by harnessing the power of AI.
What sets Vara apart is its strategic focus on simplifying detection processes, particularly through workload reduction, This approach has garnered widespread enthusiasm among radiologists, who appreciate the seamless integration of Vara's technology into their existing workflows.
While originating in Germany, Vara now sets its sights on expanding its footprint across Europe, aiming to offer its cutting-edge solutions to a broader international audience. Additionally, the company is exploring new avenues for its extensive data stores, further strengthening its position as a leading player in the field of AI-driven healthcare solutions. By continuously innovating and expanding its reach, Vara is poised to make a meaningful impact on breast cancer detection, potentially improving outcomes for countless women around the world.
Freddie
Company Specialist
Founders
Jonas Muff
(CEO)Previously Jonas worked at a venture studio called Merantix from which he successfully spun out another German HealthTech startup called MX Healthcare.
Stefan Bunk
(CTO)Created venture studio Merantix's first core machine learning infrastructure before founding Vara.
Office
Jobs (6)
Software Engineering
Operations & Strategy
Product